A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia

Autor: Kane, John M., Skuban, Aleksandar, Ouyang, John, Hobart, Mary, Pfister, Stephanie, McQuade, Robert D., Nyilas, Margaretta, Carson, William H., Sanchez, Raymond, Eriksson, Hans
Zdroj: In Schizophrenia Research May 2015 164(1-3):127-135
Databáze: ScienceDirect